Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
NCT07001878Phase 4Recruiting
- Sponsor
- Nova Scotia Health
- Start
- Mar 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in psychosis, cannabis use disorder (CUD), sponsored by Nova Scotia Health. Started Mar 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
psychosiscannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT07001878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07001878.